284 related articles for article (PubMed ID: 32777353)
1. Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways.
Mozaffari Nejad AS; Fotouhi F; Mehrbod P; Keshavarz M; Alikhani MY; Ghaemi A
Microb Pathog; 2020 Oct; 147():104438. PubMed ID: 32777353
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis.
Keshavarz M; Nejad ASM; Esghaei M; Bokharaei-Salim F; Dianat-Moghadam H; Keyvani H; Ghaemi A
Saudi J Biol Sci; 2020 Jan; 27(1):47-52. PubMed ID: 31889816
[TBL] [Abstract][Full Text] [Related]
3. Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells.
Meng G; Xia M; Wang D; Chen A; Wang Y; Wang H; Yu D; Wei J
Oncotarget; 2014 Aug; 5(15):6365-74. PubMed ID: 25051374
[TBL] [Abstract][Full Text] [Related]
4. Autophagy inhibition suppresses Newcastle disease virus-induced cell death by inhibiting viral replication in human breast cancer cells.
Rozilah MI; Yusoff K; Chia SL; Ismail S
Virology; 2024 Feb; 590():109957. PubMed ID: 38100982
[TBL] [Abstract][Full Text] [Related]
5. Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors.
Mozaffari Nejad AS; Fotouhi F; Mehrbod P; Alikhani MY
Saudi J Biol Sci; 2021 Oct; 28(10):5833-5840. PubMed ID: 34588898
[TBL] [Abstract][Full Text] [Related]
6. Newcastle disease virus strain AF2240 as an oncolytic virus: A review.
Kalyanasundram J; Hamid A; Yusoff K; Chia SL
Acta Trop; 2018 Jul; 183():126-133. PubMed ID: 29626432
[TBL] [Abstract][Full Text] [Related]
7. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
[TBL] [Abstract][Full Text] [Related]
8. Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF-κB pathway in canine mammary carcinoma cells.
Wang J; Li M; Li M
Vet Comp Oncol; 2023 Sep; 21(3):520-532. PubMed ID: 37282822
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells.
Jiang K; Li Y; Zhu Q; Xu J; Wang Y; Deng W; Liu Q; Zhang G; Meng S
BMC Cancer; 2014 Jul; 14():551. PubMed ID: 25078870
[TBL] [Abstract][Full Text] [Related]
10. The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model.
He J; An Y; Qi J; Cui L; Yang K; Liu M; Qu B; Yan S; Yin J; Jing X; Dong H; Yu Q; Li D; Wu Y
J Med Virol; 2021 Jun; 93(6):3890-3898. PubMed ID: 32779745
[TBL] [Abstract][Full Text] [Related]
11. Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells.
Wang X; Shao X; Gu L; Jiang K; Wang S; Chen J; Fang J; Guo X; Yuan M; Shi J; Ding C; Meng S; Xu Q
J Cell Mol Med; 2020 Apr; 24(7):4286-4297. PubMed ID: 32100392
[TBL] [Abstract][Full Text] [Related]
12. Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo.
Alabsi AM; Ali R; Ideris A; Omar AR; Bejo MH; Yusoff K; Ali AM
Leuk Res; 2012 May; 36(5):634-45. PubMed ID: 22133641
[TBL] [Abstract][Full Text] [Related]
13. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of newcastle disease virus strain D90 on human lung cancer cell line A549.
Fu F; Zhao M; Yang YJ; Tong GZ; Yang BF; Song C; Li X
Oncol Res; 2011; 19(7):323-33. PubMed ID: 21936402
[TBL] [Abstract][Full Text] [Related]
15. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
[TBL] [Abstract][Full Text] [Related]
16. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death.
Elankumaran S; Rockemann D; Samal SK
J Virol; 2006 Aug; 80(15):7522-34. PubMed ID: 16840332
[TBL] [Abstract][Full Text] [Related]
17. The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.
Samadi M; Mokhtari-Azad T; Nejati A; Norooz-Babaei Z; Foroushani AR; Haghshenas MR; Adjaminejad F; Zargaran H; Salimi V; Ghaemi A
BMC Cancer; 2023 Aug; 23(1):803. PubMed ID: 37641004
[TBL] [Abstract][Full Text] [Related]
18. Caspase Dependent and Independent Anti-hematological Malignancy Activity of AMHA1 Attenuated Newcastle Disease Virus.
Mohammed MS; Al-Taee MF; Al-Shammari AM
Int J Mol Cell Med; 2019; 8(3):211-223. PubMed ID: 32489950
[TBL] [Abstract][Full Text] [Related]
19. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
Kousar K; Naseer F; Abduh MS; Anjum S; Ahmad T
Front Immunol; 2023; 14():1175535. PubMed ID: 37283735
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the oncolytic property of recombinant Newcastle disease virus strain R2B in 4T1 and B16-F10 cells in-vitro.
Ramamurthy N; Pathak DC; D'Silva AL; Batheja R; Mariappan AK; Vakharia VN; Chellappa MM; Dey S
Res Vet Sci; 2021 Oct; 139():159-165. PubMed ID: 34332418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
